Average Co-Inventor Count = 3.72
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galderma Research & Development (15 from 222 patents)
2. Galderma Research & Development Snc (1 from 29 patents)
16 patents:
1. 10048279 - Method for the diagnosis of rosacea
2. 9889126 - Use of naratriptan in the treatment of rosacea
3. 9408793 - Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions
4. 8383652 - Biaromatic compounds that modulate PPAR-receptors
5. 8022079 - Methods of modulating PPAR gamma-type receptors
6. 7973063 - Methods for activating PPAR gamma-type receptors
7. 7968560 - Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
8. 7807669 - Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
9. 7626054 - Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof
10. 7625914 - Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11. 7582663 - Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
12. 7452878 - Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
13. 7307078 - Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
14. 7285568 - Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
15. 7125869 - Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof